About Index Trending news
Analyze
Pricing
DelMar Pharma

DelMar Pharma

DelMar Pharma

DelMar Pharma ($DMPI) develops #cancer therapies in new indications where patients have failed or are unlikely to respond to modern therapy. #Glioblastoma

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$9,000,000
Post-IPO equity
$5,600,000
Employees

Unknown size

Locations
HQ
Headquarters
$9,000,000 Post-IPO equity
Drug Delivery Business

DelMar closes $9m public offering